Modified transketolase and use thereof

Patent metadata

Field	Value
Publication number	US-9315784-B2
Application number	US-201213558517-A
Country	US
Kind code	B2
Filing date	Jul 26, 2012
Priority date	Nov 2, 2005
Publication date	Apr 19, 2016
Grant date	Apr 19, 2016

Abstract

The present invention relates to a improved process for the biotechnological production of compounds for which ribose-5-phosphate, ribulose-5-phosphate or xylulose-5-phosphate is biosynthetic precursor like riboflavin (vitamin B 2 ), FAD, FMN, pyridoxal phosphate (vitamin B 6 ), guanosine, GMP, adenosine, AMP. The invention further pertains to the generation of the organism producing those compounds. It furthermore relates to the generation of mutated transketolases that allow normal growth on glucose but reduced growth on gluconate when introduced into the production strains and to polynucleotides encoding them.

First claim

The invention claimed is:

1. A modified transketolase originated from Bacillus or Corynebacterium , wherein the amino acid sequence of the modified transketolase contains at least one mutation, so that the specific activity of the modified enzyme is reduced in comparison to the corresponding non-modified wild-type enzyme, said at least one mutation leading to a reduced activity of between 10 to 90% towards metabolism of carbon sources that are exclusively metabolized by the pentose phosphate pathway compared to the activity of the respective non-modified wild-type enzyme.

2. A recombinant host cell comprising the modified transketolase according to claim 1 , wherein the growth rate on a carbon source that is exclusively metabolized by the pentose phosphate pathway is reduced to between 10 to 90% in comparison to the growth rate of the respective host cell containing the wild-type transketolase.

3. A modified transketolase used in a process for producing riboflavin, wherein at least one mutation is introduced such that, in the process for producing riboflavin, after replacing the wild-type transketolase(s) of a riboflavin-producing host cell with the modified one, the growth rate of the generated new strain on a carbon source that is metabolized exclusively by the pentose phosphate pathway is reduced in comparison to the growth rate of the original host cell containing the wild-type transketolase to a growth rate of between 10 to 90% in comparison to the host cell containing the wild-type transketolase.

4. A process for the production of a substance for which ribose-5-phosphate, ribulose-5-phosphate, or xylulose-5-phosphate is a biosynthetic precursor comprising:
a) culturing the recombinant host cell of claim 2 in fermentation medium, wherein the substance is produced; and
b) separating the substance from the medium.

5. The process according to claim 4 , wherein as the substance riboflavin, a riboflavin precursor, FMN, FAD, pyridoxal phosphate or one or more derivatives thereof is/are produced.

6. The process according to claim 5 , wherein riboflavin or derivatives thereof are produced.

Assignees

• Hans Michael
• Laudert Dietmar
• Hohmann Hans-Peter
• Lehmann Martin
• Dsm Ip Assets Bv

Inventors

• Hans Michael
• Laudert Dietmar
• Hohmann Hans-Peter
• Lehmann Martin

Classifications

• C12P17/12

  containing a six-membered hetero ring · CPC title

• C12P25/00

  Preparation of compounds containing alloxazine or isoalloxazine nucleus, e.g. riboflavin · CPC title

• C12N9/1022 Primary

  transferring aldehyde or ketonic groups (2.2) · CPC title

• C12N9/10 Primary

  Transferases (2.) (ribonucleases C12N9/22) · CPC title